Home/Specialty/Microbiology/System, Nucleic Acid Amplification Test, Dna, Methicillin Resistant Staphylococcus Aureus, Direct Specimen
System, Nucleic Acid Amplification Test, Dna, Methicillin Resistant Staphylococcus Aureus, Direct Specimen
Main Filters
System, Nucleic Acid Amplification Test, Dna, Methicillin Resistant Staphylococcus Aureus, Direct Specimen
BECTON, DICKINSON AND COMPANY | ||||
CATALOG # | QTY | PRICE | DESCRIPTION | |
443419 | 0 | - | ||
443461 | 0 | - |
CEPHEID | ||||
CATALOG # | QTY | PRICE | DESCRIPTION | |
GXMRSA-100N-10 | 0 | - | ||
GXMRSA-120 | 0 | - | ||
GXMRSA-NXG-10 | 0 | - | ||
GXMRSA-NXG-120 | 0 | - | ||
GXMRSA/SA-BC-10 | 0 | - | ||
GXMRSA/SA-SSTI-10 | 0 | - | ||
GXSACOMP-10 | 0 | - | ||
GXSACOMP-120 | 0 | - |
Elitechgroup Mdx LLC | ||||
CATALOG # | QTY | PRICE | DESCRIPTION | |
M800346 | 0 | - |
Geneohm Sciences Canada Inc | ||||
CATALOG # | QTY | PRICE | DESCRIPTION | |
441448 | 0 | - | ||
441637 | 0 | - | ||
441638 | 0 | - | ||
441639 | 0 | - | ||
442953 | 0 | - |
LUMINEX CORPORATION | ||||
CATALOG # | QTY | PRICE | DESCRIPTION | |
20-006-018 | 0 | - | ||
20-009-018 | 0 | - | ||
20-011-018 | 0 | - | ||
50-10034 | 0 | - |
NANOSPHERE, INC. | ||||
CATALOG # | QTY | PRICE | DESCRIPTION | |
20-006-018 | 0 | - | ||
20-009-018 | 0 | - | ||
20-011-018 | 0 | - |
Roche Molecular Systems, Inc. | ||||
CATALOG # | QTY | PRICE | DESCRIPTION | |
05205727190 | 0 | - | ||
05205743190 | 0 | - | ||
06768113190 | 0 | - | ||
06768172190 | 0 | - | ||
06768288190 | 0 | - |
28 Results
Results Per Page
- 50
- 100
- 250
Catalog #
AvailableQty
Starting At
Name
Company Name
Description
0
-
MRSA/SA ELITe MGB
Elitechgroup Mdx LLC
MRSA/SA ELITe MGB™ is a qualitative in vitro diagnostic test for the direct detection of Staphylococcus aureus (SA) and methicillin-resistant Staphylococcus aureus (MRSA) DNA purified from nasal swabs. MRSA/SA ELITe MGB™ is intended to aid in the prevention and control of MRSA infections in healthcare settings. It is not intended to diagnose MRSA infections or to guide or monitor treatment for MRSA infections. A negative result does not preclude MRSA/SA nasal colonization. Concomitant cultures are necessary to recover organisms for epidemiological typing or for further susceptibility testing.
0
-
Gram-Positive Blood Culture (BC-GP) Utility Tray
NANOSPHERE, INC.
The Verigene® Gram-Positive Blood Culture Nucleic Acid Test (BC-GP) performed using the sample-to-result Verigene® System is a qualitative, multiplexed in vitro diagnostic test for the simultaneous detection and identification of potentially pathogenic gram-positive bacteria which may cause bloodstream infection (BSI).
0
-
Gram-Positive Blood Culture (BC-GP) Extraction Tray
NANOSPHERE, INC.
The Verigene® Gram-Positive Blood Culture Nucleic Acid Test (BC-GP) performed using the sample-to-result Verigene® System is a qualitative, multiplexed in vitro diagnostic test for the simultaneous detection and identification of potentially pathogenic gram-positive bacteria which may cause bloodstream infection (BSI).
0
-
Gram-Positive Blood Culture (BC-GP) Nucleic Acid Test Cartridge
NANOSPHERE, INC.
The Verigene® Gram-Positive Blood Culture Nucleic Acid Test (BC-GP) performed using the sample-to-result Verigene® System is a qualitative, multiplexed in vitro diagnostic test for the simultaneous detection and identification of potentially pathogenic gram-positive bacteria which may cause bloodstream infection (BSI).
0
-
Gram-Positive Blood Culture (BC-GP) Utility Tray
LUMINEX CORPORATION
The Verigene® Gram-Positive Blood Culture Nucleic Acid Test (BC-GP) performed using the sample-to-result Verigene® System is a qualitative, multiplexed in vitro diagnostic test for the simultaneous detection and identification of potentially pathogenic gram-positive bacteria which may cause bloodstream infection (BSI).
0
-
Gram-Positive Blood Culture (BC-GP) Extraction Tray
LUMINEX CORPORATION
The Verigene® Gram-Positive Blood Culture Nucleic Acid Test (BC-GP) performed using the sample-to-result Verigene® System is a qualitative, multiplexed in vitro diagnostic test for the simultaneous detection and identification of potentially pathogenic gram-positive bacteria which may cause bloodstream infection (BSI).
0
-
Gram-Positive Blood Culture (BC-GP) Nucleic Acid Test Cartridge
LUMINEX CORPORATION
The Verigene® Gram-Positive Blood Culture Nucleic Acid Test (BC-GP) performed using the sample-to-result Verigene® System is a qualitative, multiplexed in vitro diagnostic test for the simultaneous detection and identification of potentially pathogenic gram-positive bacteria which may cause bloodstream infection (BSI).
0
-
ARIES® MRSA Assay
LUMINEX CORPORATION
The ARIES® MRSA Assay is an integrated real-time polymerase chain reaction (PCR) based qualitative in vitro diagnostic test for the direct detection of methicillin–resistant Staphylococcus aureus (MRSA) DNA from nasal swabs in patients at risk for nasal colonization
0
-
BD GeneOhm™ MRSA ACP Assay (48 tests)
Geneohm Sciences Canada Inc
BD GeneOhm™ MRSA ACP Assay (48 tests)